In a potential new milestone in agricultural biotechnology, a gene-edited tomato is believed to fight cancer and heart disease. Developed in England, researchers say the deep purple tomato contains high levels of anthocyanins, which are found in berries and other fruit.
USDA has formally decided that the tomato does not warrant regulation because it is not a plant pest risk. Rabobank predicts products like this will take off in the market in the next several years.
Related:
Rabobank: Gene-edited plants will grow in the next five years
It’s all about supporting tomatoes from the “ground up”
Which “perfectly delicious” cherry tomato is right for you?
